A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma
一项针对达雷妥尤单抗难治性多发性骨髓瘤患者的塞利尼索联合达雷妥尤单抗的IIb期研究
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.287053
Biran, Noa; Zolotov, Eli; Vesole, David; Parmar, Harsh; Phull, Pooja; Doucette, Kimberley; Roney, Patrick; Ahn, Jaeil; Feinman, Rena; Zenreich, Joshua; Anand, Palka; Pace, Monique; Pia, Alexandra Della; DeAgresta, Bianca; Biamonte, Lisa; Aleman, Adolfo; Rutanen, Ella; Chappell, Aimee; Kumka, Susan; Siegel, David S